Niels Prins, MD, provides a brief introduction to the progression of AD and explains the benefits of early diagnosis. He goes on to present a conceptual framework for the diagnostic journey, which aims to optimize AD management, before focusing on the first part of that journey: patient detection. He then outlines several key considerations for the detection of patients with AD and describes key focus areas for the improvement of detection processes, with an emphasis on education and training for non-dementia-trained healthcare professionals (HCPs).
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.